PRC
MDCO

Platte River Capital’s Medicines Co MDCO Stock Holding History

Platte River Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,810
Closed -$481K – 161
2015
Q2 		$481K Sell
16,810
-6,590
-28% -$184K 0.24% 104
2015
Q1 		$656K Buy
+23,400
New +$657K 0.29% 90

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Platte River Capital's MDCO Position: Q3 2015 in Review

Platte River Capital sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 16,810 shares — an estimated $481K sold.

Platte River Capital first reported a position in MDCO in Q1 2015 and held it in 2 quarters. The position peaked at $656K in Q1 2015. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

  • Platte River Capital reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
  • Platte River Capital sold 16,810 Medicines Co shares in Q3 2015, an estimated $481K.
  • Platte River Capital first reported a position in Medicines Co in Q1 2015 and held it in 2 quarters.
  • Platte River Capital's Medicines Co position peaked at $656K in Q1 2015.
  • 183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.